Zacks Value Investor Highlights: HRMY, NVDA and VLO

For Immediate Release

Chicago, IL – July 27, 2026 – Zacks Value Investor is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here: https://www.zacks.com/stock/news/1865929/whats-working-in-2022-value-stocks)

How Many Stocks Should You Own?

Welcome to Episode #448 of the Value Investor Podcast.

• (0:20) - How Big Should Your Portfolio Really Be?
• (4:00) - Diversifying Your Investments Depending On Your Portfolio
• (12:45) - Finding Strong Investments For Your Watchlist Right Now
• (32:30) - Episode Roundup: HRMY, NVDA, VLO
•                 Podcast@zacks.com

 Every week, Tracey Ryniec, the editor of Zacks Value Investor portfolio, shares some of her top value investing tips and stock picks.

There’s a question which every investor should ask, not only value investors, which is: how many stocks should you own?

Berkshire Hathaway’s Ted Weschler has said in interviews about his multi-million-dollar Roth IRA that he grew it by concentrating on a few winning positions.

Warren Buffett himself has said in interviews that an investor can be “diverse” with as few as three stock positions.

But all of us aren’t Warren Buffett, who has the opportunity to closely vet the companies he buys.

Studies of “average” investors have shown that there can be diversity with a stock portfolio between 10 and 20 stocks.

What is “Diversity” and why is it Important for Investors?

You can own 30 stocks and believe that you are spreading your risk, but if all the companies are in the same sector, you probably aren’t that diverse.

Additionally, what if you own all large caps? Currently, large cap stocks are outperforming the small cap stocks, and have been for a few years in a row, but what happens when the small caps come back into favor?

If you own a portfolio with all large cap stocks, you will underperform.

Diversity means owning stocks in many different sectors and industries as well as owning a mix of market caps. It’s easy to think the latest red-hot industry will always be hot. Many investors thought the banks were “safe” in the early 2000s.

For most investors, it’s best to follow the adage: “don’t put all your eggs in one basket.”

Owning Value and Growth Stocks

While this is a podcast devoted to value stock investing, even value investors should be diverse. There’s no reason for value investors to eschew growth stocks completely.

Buying companies that have both growth and which are still values is the best of both worlds.

Screening with the PEG Ratio to Find Cheap Stocks with Growth

To find companies that have growth but are also attractively valued, Tracey screened with the PEG ratio. The PEG ratio is the price-to-earnings (P/E) ratio divided by the earnings growth.

A PEG ratio under 1.0 usually indicates a company has both growth and value.

But just looking for a low PEG ratio isn’t enough. Tracey screened for the Zacks Ranks of #1 (Strong Buy) and #2 (Buy) as well. A high Zacks Rank usually means the analysts are raising earnings estimates. That’s a bullish sign.

The screen also looked for stocks over $5 as well as those with Average Broker Recommendations under 2.5.

This screen returned just 18 stocks.

3 Stocks with PEG Ratios Under 1.0

1. Harmony Biosciences Holdings, Inc. HRMY

Harmony Biosciences is a pharmaceutical company which is developing therapies for patients with rare neurological diseases who have unmet medical needs. On July 16, 2026, Harmony pre-announced record quarterly revenue for the second quarter and reaffirmed its 2026 revenue guidance of $1.0 to $1.04 billion, a company record.

Harmony Biosciences produces WAKIX for narcolepsy. Earnings are expected to rise 21.8% in 2026. It’s cheap, with a forward P/E of just 10.8. A P/E under 15 usually indicates value.

Shares of Harmony Biosciences are down 5.6% year-to-date even with record quarterly revenue. It reports its full second quarter results on Aug 4, 2026.

Harmony Biosciences is a Zacks Rank #1 (Strong Buy).

Should a cheap pharmaceutical company with double digit earnings growth like Harmony Biosciences be on your short list?

2. NVIDIA Corp. NVDA

NVIDIA made it into a value stock screen and is being featured on the Value Investor Podcast? What is the world coming to?

This $5 trillion market cap GPU juggernaut is expected to grow earnings by 90.6% in fiscal 2027 even after growing earnings 59.5% in fiscal 2026. The Street, and skeptics, keep waiting for earnings growth to slow. But, instead, it’s accelerating.

Shares of NVIDIA are up just 10.5% year-to-date, however. It trades with a forward P/E of 23. While that’s not a classic valuation of 15 or under, for NVIDIA, that’s a historically low P/E ratio.

Because of the massive earnings growth, NVIDIA sports a PEG ratio of just 0.39.

NVIDIA is a Zacks Rank #1 (Strong Buy).

Should value investors be accumulating shares of NVIDIA right now?

3. Valero Energy Corp. VLO

Valero Energy Corp. manufactures and markets petroleum-based and low-carbon liquid transportation fuels and petroleum products in the US, Canada, the United Kingdom, Ireland and Latin America. Valero operates 14 petroleum refineries with a combined throughput capacity of about 3 million barrels per day.

The crack spreads have risen during the Iran War which means so have Valero’s earnings estimates. 2026 earnings are expected to jump 230% this year to $35.11 from $10.61 last year.

Shares of Valero are up 86% year-to-date but it’s still cheap. Valero has a forward PE of just 8.7. When you combine it with explosive earnings growth, you get a PEG ratio of just 0.21. Valero has the rare combination of growth and value.

It will report second quarter earnings on July 30,2026.

Valero is a Zacks Rank #2 (Buy) stock.

Have investors missed their chance to buy Valero earlier in the year or is there still more upside?

What Else Should You Know About Stocks with Value and Growth?  

Tune into this week’s podcast to find out.

Why Haven't You Looked at Zacks' Top Stocks?

Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.

Today you can access their live picks without cost or obligation.

See Stocks Free >>

Tracey Ryniec is the Value Stock Strategist for Zacks.com. She is also the Editor of the Insider Trader and Value Investor services. You can follow her on twitter at @TraceyRyniec and she also hosts the Zacks Market Edge Podcast on iTunes.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros.  In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time!  Click here for your free subscription to Profit from the Pros.

Join us on Facebook:  https://www.facebook.com/ZacksInvestmentResearch/

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com/performance

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research